FlowMD Feasibility Study (FLowMD)

National University of Natural Medicine (NUNM)

Status: Enrolling

Conditions: Anxiety

Treatments: Other: Intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT07672925

HZ71724

Details and patient eligibility

About

The goal of this clinical trial is to learn if the FlowMD mobile app is feasible to be used to manage mild anxiety in adults. It will also learn if the app is effective at managing anxiety in adults.

Participants will:

Use the FlowMD app daily to complete a 1-5 minute guided breathwork session over the course of 4 weeks.

Complete surveys at the beginning, midpoint, and end of the study to measure anxiety levels and usability of the app.

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Are 18-65 years old
• Have an anxiety disorder
• Have a smartphone
• Able to download the FlowMD app
• Willing to use the FlowMD meditation app for a daily 1-5 minute session for four consecutive weeks
• Able to provide feedback on the experience using the app
• Willing to participate in surveys to measure changes in anxiety levels

Exclusion criteria

• Are undergoing significant changes in psychiatric medication or therapy
• Have severe psychiatric conditions that might interfere with study participation (Schizophrenia, Bipolar Disorder, Major Depressive Disorder)

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Intervention

Active Comparator group

Description:

Daily guided breathwork using the FlowMD mobile app

Treatment:

Other: Intervention

Control

No Intervention group

Description:

Control Group with no Intervention